| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.057 | 0.05 |